Miyuki Mori

Pravastatin improves renal ischemia–reperfusion injury by inhibiting the mevalonate pathway

Satoru Sharyo, Naoko Yokota‐Ikeda, Miyuki Mori et al. · Kidney International · 2008 · 60 citations · Full text

Medicine, Nephrology, Pharmacology +14

Ocular symptoms associated with a dural arteriovenous fistula involving the hypoglossal canal: selective transvenous coil embolization

Hiro Kiyosue, Shuichi Tanoue, Mika Okahara et al. · Journal of neurosurgery · 2001 · 57 citations

Medicine, Neurosurgery, Surgery +16

The Modified High-Density Survival Assay is the Useful Tool to Predict the Effectiveness of Fractionated Radiation Exposure

Yoshikazu Kuwahara, Miyuki Mori, Toshiyuki Oikawa et al. · Journal of Radiation Research · 2010 · 47 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Targeting of tumor endothelial cells combining 2 Gy/day of X‐ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors

Yoshikazu Kuwahara, Miyuki Mori, Shuji Kitahara et al. · Cancer Medicine · 2014 · 39 citations · Full text

Medicine, Oncology, Pharmacology +13

<i>In vitro</i> Induction of Cytotoxic T Lymphocytes against HTLV‐I‐infected T‐Cells from Adult T‐Cell Leukemia Patients, Asymptomatic HTLV‐I Carriers and Seronegative Healthy Donors

Yoshihiko Katahira, Shinji Yashiki, Toshinobu Fujiyoshi et al. · Japanese Journal of Cancer Research · 1995 · 26 citations

Life Sciences, Immunology, Oncology +15